{"filing":{"accession_number":"0001650664-26-000063","cik":"0001650664","ticker":"EDIT","company_name":"Editas Medicine, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"edit-20260617.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000063/edit-20260617.htm"},"events":[{"id":11887,"run_id":10461,"accession_number":"0001650664-26-000063","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 filing discloses the results of Editas Medicine's 2026 Annual Meeting of Stockholders held on June 17, 2026, including voting outcomes on three matters: election of Class I directors (Bernadette Connaughton and Elliott Levy, M.D.), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents vote tallies (For, Against, Withheld, Abstaining, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.","company_name":"Editas Medicine, Inc.","ticker":"EDIT","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8594,"accession_number":"0001650664-26-000063","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the results of Editas Medicine's 2026 Annual Meeting of Stockholders held on June 17, 2026, including voting outcomes on three matters: election of Class I directors (Bernadette Connaughton and Elliott Levy, M.D.), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents vote tallies (For, Against, Withheld, Abstaining, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:30:06.121226+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8594,"accession_number":"0001650664-26-000063","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the results of Editas Medicine's 2026 Annual Meeting of Stockholders held on June 17, 2026, including voting outcomes on three matters: election of Class I directors (Bernadette Connaughton and Elliott Levy, M.D.), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents vote tallies (For, Against, Withheld, Abstaining, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:30:06.121226+00:00","company_name":"Editas Medicine, Inc.","ticker":"EDIT","filing_date":"2026-06-18"}]}